ALANA BRADBURY: Open Payments
NPI 1982202446 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 77 payments from 22 companies in 2025. Trend: 2023 $1,131 · 2024 $1,205 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $354 |
| PFIZER INC. | 8 | $143 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Aimmune Therapeutics, Inc. | 5 | $87 |
| Boston Scientific Corporation | 4 | $85 |
| Amgen Inc. | 3 | $65 |
| Lilly USA, LLC | 4 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
Products named: UBRELVY, QULIPTA, VRAYLAR, ZENPEP, REXULTI, General - Pain Management, FARXIGA, PREVNAR 20.
Industry payments across UT — which companies pay providers there.
